Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson's disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

被引：0
|
作者：
Zhang, P. [1 ]
Li, Y. [1 ]
Wang, L. J. [1 ]
Zhang, Y. H. [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Neurosci Inst, Guangzhou, Peoples R China
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
454
引用
收藏
页码：S191 / S192
页数：2
相关论文
共 50 条
  • [1] Dissociable contribution of serum NfL and p-tau181 to cognitive impairment and mild cognitive impairment in Parkinson's disease
    Pagonabarraga, J.
    Perez-Gonzalez, R.
    Bejr-kasem, H.
    Horta-Barba, A.
    Aracil-Bolanos, I.
    Martinez-Horta, S.
    Rivas-Asensio, E.
    Perez-Perez, J.
    Sampedro, F.
    Campolongo, A.
    Izquierdo, C.
    Pascual-Sedano, B.
    Kulisevsky, J.
    MOVEMENT DISORDERS, 2021, 36 : S297 - S297
  • [2] Elevated CSF p-tau181 and total-tau and reduced p-tau181/t-tau ratio in pre-symptomatic familial Alzheimer's disease
    Ringman, John M.
    Seltzer, Willam
    Cole, Greg
    Medina, Luis D.
    Rodriguez, Yaneth
    Varpetian, Arousiak
    Sokolow, Sophie
    Fitten, Jaime
    Ortiz, Freddy
    Cummings, Jeffrey L.
    NEUROLOGY, 2008, 70 (11) : A183 - A183
  • [3] Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
    Pagonabarraga, Javier
    Perez-Gonzalez, Rocio
    Bejr-kasem, Helena
    Marin-Lahoz, Juan
    Horta-Barba, Andrea
    Martinez-Horta, Saul
    Aracil-Bolanos, Ignacio
    Sampedro, Frederic
    Campolongo, Antonia
    Rivas, Elisa
    Puig-Davi, Arnau
    Ruiz-Barrios, I.
    Perez-Perez, Jesus
    Pascual-Sedano, Berta
    Kulisevsky, Jaime
    PARKINSONISM & RELATED DISORDERS, 2022, 105 : 132 - 138
  • [4] Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment
    Schedin-Weiss, Sophia
    Gaunitz, Stefan
    Sui, Ping
    Chen, Qiushi
    Haslam, Stuart M.
    Blennow, Kaj
    Winblad, Bengt
    Dell, Anne
    Tjernberg, Lars O.
    FEBS JOURNAL, 2020, 287 (15) : 3221 - 3234
  • [5] Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
    Kang, Ju-Hee
    Irwin, David J.
    Chen-Plotkin, Alice S.
    Siderowf, Andrew
    Caspell, Chelsea
    Coffey, Christopher S.
    Waligorska, Teresa
    Taylor, Pegg
    Pan, Sarah
    Frasier, Mark
    Marek, Kenneth
    Kieburtz, Karl
    Jennings, Danna
    Simuni, Tanya
    Tanner, Caroline M.
    Singleton, Andrew
    Toga, Arthur W.
    Chowdhury, Sohini
    Mollenhauer, Brit
    Trojanowski, John Q.
    Shaw, Leslie M.
    JAMA NEUROLOGY, 2013, 70 (10) : 1277 - 1287
  • [6] Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis
    Hu, Xiaohui
    Yang, Yan
    Gong, Daokai
    NEUROLOGICAL SCIENCES, 2017, 38 (11) : 1953 - 1961
  • [7] Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson’s disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis
    Xiaohui Hu
    Yan Yang
    Daokai Gong
    Neurological Sciences, 2017, 38 : 1953 - 1961
  • [8] Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
    Janelidze, Shorena
    Stomrud, Erik
    Smith, Ruben
    Palmqvist, Sebastian
    Mattsson, Niklas
    Airey, David C.
    Proctor, Nicholas K.
    Chai, Xiyun
    Shcherbinin, Sergey
    Sims, John R.
    Triana-Baltzer, Gallen
    Theunis, Clara
    Slemmon, Randy
    Mercken, Marc
    Kolb, Hartmuth
    Dage, Jeffrey L.
    Hansson, Oskar
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [9] Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease
    Pilotto, Andrea
    Parigi, Marta
    Bonzi, Giulio
    Battaglio, Beatrice
    Ferrari, Elisabetta
    Mensi, Lorenza
    Benussi, Alberto
    Caratozzolo, Salvatore
    Cosseddu, Maura
    Turrone, Rosanna
    Archetti, Silvana
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Giliani, Silvia
    Padovani, Alessandro
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 87 (03) : 991 - 997
  • [10] Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
    Shorena Janelidze
    Erik Stomrud
    Ruben Smith
    Sebastian Palmqvist
    Niklas Mattsson
    David C. Airey
    Nicholas K. Proctor
    Xiyun Chai
    Sergey Shcherbinin
    John R. Sims
    Gallen Triana-Baltzer
    Clara Theunis
    Randy Slemmon
    Marc Mercken
    Hartmuth Kolb
    Jeffrey L. Dage
    Oskar Hansson
    Nature Communications, 11
12345